tHEORetically Speaking
Avsnitt

Weekly News Roundup — mRNA Vaccine Milestones, Obesity Drug Manufacturing, and Gene Therapy Regulatory Tensions

tHEORetically Speaking
Dela

This week’s tHEORetically Speaking News Roundup covers Moderna’s progress toward European approval of its combination COVID-19 and flu mRNA vaccine, Novo Nordisk’s $501 million investment to expand Wegovy pill production in Ireland, and Moderna’s $2.25 billion settlement resolving a major mRNA patent dispute. We also explore the FDA’s disagreement with uniQure over clinical trial requirements for its Huntington’s gene therapy. 

Tune in for this concise recap of the key developments shaping the life sciences and market access landscape. 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör HealthEconomics.com. Innehållet i podden är skapat av HealthEconomics.com och inte av, eller tillsammans med, Poddtoppen.